Background
The Cleveland Clinic and IBM Discovery Accelerator, established in 2021 as part of a decade-long partnership, aims to accelerate biomedical discovery by applying high-performance computing (HPC), artificial intelligence (AI), and quantum computing. This initiative addresses critical challenges in fields such as drug discovery, disease mechanism elucidation, and advancing personalized medicine.
Biomedical research, particularly drug discovery, is highly data-intensive, often taking over a decade and costing billions of dollars. While HPC and AI have significantly accelerated these processes, quantum computing holds the potential to open new frontiers unattainable by classical methods. These include the precise simulation of molecular-level interactions and the recognition of complex biomarker patterns. Quantum computing, in particular, offers novel approaches to molecular dynamics simulations and protein folding problems, which are computationally intractable for classical computers. This partnership between Cleveland Clinic and IBM is a pioneering initiative to establish leadership in quantum technology within the healthcare sector.
Key Findings
In its five years since establishment, the Discovery Accelerator program has supported over 50 biomedical research projects, integrating applications of quantum computing and AI.
A groundbreaking technical achievement is the successful quantum computer simulation of a massive protein structure exceeding 12,000 atoms. This represents the largest protein ever modeled by a quantum computer and showcases the significant potential of quantum technology to dramatically advance molecular modeling in drug discovery and the understanding of complex biomolecular interactions. Traditionally, such large-scale simulations required immense computational resources and time, often pushing the limits of classical methods.
Furthermore, the program is dedicated to building educational curricula to foster a quantum-ready workforce. By training experts in quantum computing, data science, and AI, it aims to meet the future needs of biomedical research and industry, strengthening the human resource base required to accelerate the application of quantum technology in healthcare.
The success in simulating a protein with over 12,000 atoms suggests concrete potential for breakthroughs in streamlining drug discovery pipelines, developing early diagnostic tools for diseases, and designing personalized treatments. The Cleveland Clinic and IBM Discovery Accelerator will continue to expand the application of quantum computing in biomedical research, establishing quantum computing as an indispensable tool in shaping the future of healthcare and serving as a critical example to encourage other medical institutions and researchers to invest in and apply quantum technologies.
Get our weekly technology intelligence — free
Receive an infographic that lets you judge at a glance whether each field’s analysis report is worth reading.
Subscribe Free — Weekly Tech Intelligence
By subscribing, you’ll receive Troy-Technical’s weekly technology intelligence newsletter.
- Your email and selected fields are used only to deliver the newsletter.
- We never share your information with third parties.
- You can unsubscribe anytime via the link in each email.
See our Privacy Policy for details.
Takes about a minute · Unsubscribe anytime
Comments